Vanguard Group
PRCT icon

Vanguard Group’s Procept Biorobotics PRCT Stock Holding History

Vanguard Group’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$164M Sell
5,202,306
-3,136
-0.1% -$104K ﹤0.01% 1647
2025
Q3 		$186M Sell
5,205,442
-42,630
-0.8% -$1.95M ﹤0.01% 1574
2025
Q2 		$302M Buy
5,248,072
+120,935
+2% +$6.84M ﹤0.01% 1299
2025
Q1 		$299M Sell
5,127,137
-13,289
-0.3% -$907K 0.01% 1274
2024
Q4 		$414M Buy
5,140,426
+297,075
+6% +$25.4M 0.01% 1150
2024
Q3 		$388M Buy
4,843,351
+131,204
+3% +$9.32M 0.01% 1192
2024
Q2 		$288M Buy
4,712,147
+465,398
+11% +$27.7M 0.01% 1287
2024
Q1 		$210M Buy
4,246,749
+62,164
+1% +$2.96M ﹤0.01% 1488
2023
Q4 		$175M Buy
4,184,585
+109,694
+3% +$3.74M ﹤0.01% 1583
2023
Q3 		$134M Buy
4,074,891
+385,271
+10% +$13.1M ﹤0.01% 1648
2023
Q2 		$130M Buy
3,689,620
+420,850
+13% +$13.9M ﹤0.01% 1709
2023
Q1 		$92.8M Buy
3,268,770
+33,906
+1% +$1.2M ﹤0.01% 1866
2022
Q4 		$134M Buy
3,234,864
+396,340
+14% +$17M ﹤0.01% 1638
2022
Q3 		$118M Buy
2,838,524
+381,894
+16% +$15.2M ﹤0.01% 1683
2022
Q2 		$80.3M Buy
2,456,630
+1,848,617
+304% +$67.2M ﹤0.01% 1948
2022
Q1 		$21.3M Buy
608,013
+23,439
+4% +$564K ﹤0.01% 2739
2021
Q4 		$14.6M Buy
584,574
+128,780
+28% +$4.76M ﹤0.01% 3012
2021
Q3 		$17.4M Buy
+455,794
New +$17.5M ﹤0.01% 2940

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Vanguard Group's PRCT Position: Q4 2025 in Review

Vanguard Group reduced its Procept Biorobotics (PRCT) stake by 0.06% in Q4 2025, selling an estimated $104K and leaving 5,202,306 shares worth $164M. The position accounts for ﹤0.01% of the portfolio, ranked #1647.

Vanguard Group first reported a position in PRCT in Q3 2021 and has held it in 18 quarters since. The position peaked at $414M in Q4 2024. 263 funds tracked by Wall St. Rank hold PRCT as of Q4 2025.

  • Vanguard Group held 5,202,306 shares of Procept Biorobotics worth $164M as of Q4 2025.
  • Vanguard Group sold 3,136 Procept Biorobotics shares in Q4 2025, an estimated $104K.
  • Procept Biorobotics made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #1647 holding.
  • Vanguard Group first reported a position in Procept Biorobotics in Q3 2021 and has held it in 18 quarters since.
  • Vanguard Group's Procept Biorobotics position peaked at $414M in Q4 2024.
  • 263 funds tracked by Wall St. Rank held Procept Biorobotics as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.